Is It Time to Sell MercadoLibre?
MercadoLibre (NASDAQ:MELI) has earned a reputation for being not dissimilar…
Sell
44
DUFRY Quote, Financials, Valuation and Earnings
Last price:
$5.40
Seasonality move
:
-7.86%
Day range:
$5.31 - $5.45
52-week range:
$3.46 - $5.42
Dividend yield:
2.23%
P/E ratio:
69.57x
P/S ratio:
0.55x
P/B ratio:
3.00x
Volume:
58.8K
Avg. volume:
65.9K
1-year change:
30.43%
Market cap:
$7.8B
Revenue:
$15.6B
EPS (TTM):
$0.08
Avolta AG Number of Institutional Trades
Avolta AG Volume of Institutional Trades
Amount of Institutions Buying
--
(Last Month)
Amount of Institutional Buying
$11.1K
(Last 6 Months)
Current Institutional Ownership Percentage
0.01%
Amount of Institutions Selling
--
(Last Month)
Amount of Institutional Selling
$7.6M
(Last 6 Months)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Avolta AG Institutional Ownership
-
What Percentage Of DUFRY Is Owned by Institutions?
0.01% of DUFRY is owned by institutions.
-
How Many Institutions Own DUFRY Shares?
Avolta AG stock is owned by 11 institutional shareholders at this time.
-
Have Institutions Been Buying DUFRY Stock?
Yes, institutions have bought 500 shares of DUFRY in the last quarter.
-
Have Institutions Been Selling DUFRY Stock?
Yes, institutions have sold 811.7K shares of DUFRY over the last quarter.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Tesla Stock High Risk or High Reward?
EV-making supergiant Tesla, Inc. (NASDAQ:TSLA) is going through a difficult…
Why Did Chase Coleman Buy TSM?
Billionaire Chase Coleman of Tiger Global Management has built a…
Stock Ideas
Buy
65
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 48x
Buy
67
Is MSFT Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 39x
Sell
42
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Alerts
Buy
52
CTRN alert for Jun 5
Citi Trends [CTRN] is up 2.77% over the past day.
Sell
44
RGC alert for Jun 4
Regencell Bioscience Holdings [RGC] is up 3.45% over the past day.
Buy
63
MLTX alert for Jun 4
MoonLake Immunotherapeutics [MLTX] is up 5.33% over the past day.
